Back
Plus Therapeutics, Inc. 10K Form
Sell
46
PSTV
Plus Therapeutics, Inc.
Last Price:
$0.67
Seasonality Move:
3.95%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PSTV News And Ratings
See the #1 stock for the next 7 days that we like better than PSTV
PSTV Financial Statistics
Sales & Book Value
| Annual Sales: | $5.8M |
|---|---|
| Cash Flow: | $-2.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.04 |
| Price / Book: | 17.81 |
Profitability
| EPS (TTM): | -1.90420 |
|---|---|
| Net Income (TTM): | $-24.5M |
| Gross Margin: | $5M |
| Return on Equity: | 0% |
| Return on Assets: | -224.33% |
Plus Therapeutics, Inc. Earnings Forecast
Key Plus Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 27 years for PSTV is 85.37%.
-
The Selling, General & Administrative Expenses for PSTV have been equal to 170.66% of Gross Profit Margin.
-
The Research & Development expenses have been 181.66% of Revenue.
-
The Net Earning history of PSTV is -222.84% of Total Revenues.
-
Per Share Earnings over the last 27 years have been positive in 20 years.
Plus Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PSTV |
| CUSIP: | 72941H |
| Website: | plustherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 1.27 |
| Quick Ratio: | 1.22 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PSTV Technical Analysis vs Fundamental Analysis
Sell
46
Plus Therapeutics, Inc. (PSTV)
is a Sell
Is Plus Therapeutics, Inc. a Buy or a Sell?
-
Plus Therapeutics, Inc. stock is rated a SellThe current Plus Therapeutics, Inc. [PSTV] share price is $0.66. The Score for PSTV is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.